Gene Query: EXOC5

Dataset Description Geneva Score
Disruption of the exocyst induces podocyte loss and dysfunction 63.4
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 36.05
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 32.53
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 28.62
Altering cancer transcriptomes using epigenomic inhibitors 27.07
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 27.07
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 26.08
Human cell line and subcutaneous tumor 24.68
Genome wide expression change by RNF168 knocking down in MCF-7 cells 24.59
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 23.54
Knockdown of ADNP in HCT116 colon cancer cells 23.33
RNAseq analysis of ESRP regulated splicing events in prostate cancer 22.5
hTERT promotes cell adhesion and migration independent of telomerase activity 22.04
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 21.24
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 21.05
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 21.05
Ribosomal footprinting of CN34-Parental and CN34-LM1a 20.92
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 20.27
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 20.22
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 20.13
TFAP2C signalling in human fibroblasts 20.1
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 19.62
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 19.56
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 19.53
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 19.32
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 18.71
Ribosomal footprinting of MDA-Parental and MDA-LM2 18.61
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 18.41
CD73 knockdown effect in pancreatic cancer cell lines 18.35
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 17.66
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 17.59
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 17.59
Genome wide expression change by RNF168 knocking down in NEC cells 17.5
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 17.26
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 17.07
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 17.05
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 16.66
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 16.66
The contribution of Alu exons to the human proteome 16.53
FOXD3 is a novel tumor suppressor in lung cancer 16.33
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 16.26
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 16.02
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 16.02
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 15.89
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 15.8
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 15.8
Genome wide expression change in LCC2 and MCF-7 cells 15.41
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 15.33
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 15.3
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 15.14
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 15.08
RNA-seq of YB5 cells treated with Proscillaridin A 14.94
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 14.78
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 14.46
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 14.46
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 14.38
Expression data from miR340 overexpressing human A549 cells 14.1
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 13.95
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 13.88
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 13.88
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 13.87
RNAseq Study in CC-671 Treated Cal-51 Cells 13.84
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 13.71
TGF-β regulation of miRNA expression in pancreatic cancer 13.68
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 13.59
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 13.58
MYC dependent mRNA translation shapes gene expression and cell biology 13.55
RNA-Seq with and without RNase treatment in PCa cell lines 13.32
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 13.29
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 13.15
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 13.14
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 12.9
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 12.9
The transcriptome effect of overexpressing EZH2 in MCF7 12.88
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 12.75
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 12.75
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 12.75
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 12.75
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 12.53
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 12.49
Expression level comparison under dividing and quiescent states in human primary fibroblasts 12.46
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 12.35
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 12.34
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 12.21
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 12.21
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 11.93
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 11.75
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 11.74
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 11.71
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 11.71
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 11.71
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 11.7
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 11.63
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 11.62
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 11.51
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 11.48
MYCi975 regulates MYC target genes 11.48
RNA-seq analyses of human prostate cancer cells 11.47
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 11.46
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 11.38
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 11.26
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 11.21
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 11.19
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 11.14
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 11.06
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 11.06
RIG-I and MDA5 fRIP during KSHV lytic reactivation 10.99
Downregulation of DDX5/DDX17 and REST 10.95
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 10.93
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 10.92
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 10.71
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 10.68
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 10.61
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 10.56
Gene expression changes after LOC550643 silencing 10.54
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 10.47
3’ Uridylation Expands miRNA Target Repertoire 10.45
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 10.35
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 10.32
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 10.1
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 9.92
Global Mapping of Human RNA-RNA Interactions 9.9
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 9.86
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 9.82
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 9.79
Identification of Nrf2 regulated genes by RNA sequencing 9.73
Nrf2 regulated genes in A549 cells 9.73
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 9.63
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 9.58
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 9.58
SLIGRL-induced gene expression changes in NHEK cells 9.5
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 9.4
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 9.4
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 9.33
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 9.33
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 9.29
Targeting EZH2 in MYCN-amplified Neuroblastoma 9.28
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 9.28
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 9.26
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 9.26
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 9.07
Electronic cigarettes 9.06
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 9.06
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 9.02
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 8.98
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 8.98
Inhibition of TNBC metastasis by Gpx1 8.92
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 8.9
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 8.77
RNA-seq of RKO cells with cTAZ KO or putback 8.77
Effect of PBK knockdown on C4-2 cell transcriptome 8.71
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 8.71
IMP3 regulated gene expression in breast cancer cells 8.69
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 8.64
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 8.63
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 8.62
Interaction between mitoNEET and NAF-1 in cancer cells 8.49
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 8.48
Genome-wide discovery of human splicing branchpoints [RNAse] 8.41
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 8.33
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 8.33
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 8.32
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 8.3
Profiling of escape kinetics of viruses subjected to RNAi 8.29
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 8.26
Effect of ILF3 on translation during homeostasis and the antiviral response 8.21
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 8.18
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 8.16
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 8.16
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 8.16
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 8.15
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 8.15
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 8.15
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 8.14
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 8.13
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 8.12
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 8.1
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 8.1
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 8.08
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 8.08
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 8.04
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 8.04
METTL3 promotes translation in human cancer cells 8.03
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 7.99
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 7.93
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 7.92
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 7.84
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 7.83
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 7.8
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 7.77
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 7.71
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 7.71
Mapping interactions for the TNIP2 hub protein 7.67
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 7.67
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 7.63
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 7.63
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 7.63
RNAseq Analysis in glioblastoma cells treated with Mepazine 7.54
Systematic discovery of endogenous human ribonucleoprotein complexes 7.51
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 7.51
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 7.4
Exploring the RNA landscape of endothelial exosomes 7.36
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 7.36
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 7.3
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 7.26
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 7.2
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 7.13
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 7.1
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 7.08
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 7.08
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 7.05
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 7.02
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 6.93
O-glcnAc reprograms cellular energetics 6.92
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 6.92
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 6.9
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 6.89
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 6.84
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 6.78
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 6.68
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 6.58
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 6.57
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 6.49
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 6.46
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 6.46
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 6.34
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 6.3
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 6.28
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 6.26
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 6.26
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 6.22
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 6.21
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 6.21
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 6.19
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 6.14
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 6.14
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 6.11
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 6.11
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 6.09
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 6.09
The cohesin release factor WAPL restricts chromatin loop extension. 6.09
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 6.09
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 6.07
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 6.07
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 6.05
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 5.95
Solid phase chemistry to covalently and reversibly capture thiolated RNA 5.92
Effect of PRDM11 depletion in U2932 cells 5.9
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 5.87
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 5.85
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 5.78
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 5.78
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 5.64
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 5.55
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 5.44
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 5.38
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 5.38
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 5.34
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 5.32
Gene expression profile in breast cancer cells 5.32
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 5.31
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 5.3
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 5.29
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 5.27
SLAM-seq for K562 endogenous mRNA decay 5.24
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 5.2
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 5.18
The Genetic Landscape of Diamond-Blackfan Anemia 5.16
MARCKS and lnc-MARCKS act as inflammation regulators 5.1
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 5.08
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 5.06
Regulation of poly(A) tail and translation during the somatic cell cycle 4.96
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 4.92
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 4.87
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.85
RNA Sequencing of Human iPS derived Cardiomyocytes 4.85
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 4.84
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 4.84
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 4.83
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 4.81
Transcriptome of diurnal human blood neutrophils 4.78
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 4.65
K562 polyA RNA-Seq 4.62
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 4.62
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 4.62
Regulation of protein translation during mitosis 4.6
RNA-seq analysis of differentiating human erythroblasts 4.6
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 4.57
RNA-seq analysis upon ARID1B overexpression 4.53
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 4.52
RNA sequencing of matched nephrectomy samples [RNA-seq] 4.49
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 4.49
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 4.49
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 4.49
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 4.47
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 4.47
Transcriptome-wide response to synthetic chromatin protein PcTF 4.33
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 4.33
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 4.3
MAIT cell RNA sequencing 4.29
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 4.19
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 4.17
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 4.16
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 4.11
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 4.09
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 4.09
Novel Targeting of Transcription and Metabolism in Glioblastoma 4.05
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 3.99
RNA seq comparison between scrambled and shGRP78 cells 3.97
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 3.93
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 3.93
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 3.89
Gene expression profiling of leukemia cells following asparagine depletion 3.82
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 3.78
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 3.74
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 3.74
RNA-Seq of PRMT1 overexpression ECA109 cells 3.7
Exploring ILF2 regulatory genes by next-generation sequencing 3.69
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 3.63
CDK12 mediated transcriptional regulation in U2OS cells 3.57
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.52
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.52
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 3.52
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 3.47
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 3.47
RNA-seq analysis of control and Myc-induced U2OS cells 3.45
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.44
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 3.43
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 3.43
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 3.42
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 3.39
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 3.35
SOX11 knockdown in B-ALL cell lines 3.31
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 3.29
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 3.29
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 3.26
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 3.22
Endothelial gene expression analysis 3.22
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.21
FBXW7 modulates stress response by post-translational modification of HSF1 3.18
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 3.18
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 3.17
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 3.12
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 3.12
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.11
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 3.07
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 3.05
Aneuploidy-induced cellular stresses limit autophagic degradation. 2.91
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.83
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 2.82
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.8
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.79
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 2.78
The circadian transcriptional landscape in primary human mammary epithelial cells 2.75
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 2.74
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 2.73
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 2.68
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.66
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 2.65
Determination of tRNA aminoacylation levels by high throughput sequencing 2.65
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 2.64
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 2.64
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.61
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 2.54
Splicing and epigenetic factors jointly regulate epidermal differentiation 2.44
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 2.37
p63 controls the enhancer landscape during keratinocyte differentiation 2.36
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 2.32
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.27
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 2.25
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.19
mRNA expression in human DAOY cells 2.15
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 2.15
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 2.14
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 2.14
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 2.14
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 2.09
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 2.08
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 2.07
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.07
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.04
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 2.04
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.99
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.98
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.97
Ribosomal protein RPL26 is the principal target of UFMylation 1.95
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 1.95
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 1.93
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.92
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.92
LINE-2 transposable elements are a source of functional human microRNAs and target sites 1.89
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.88
MicroRNA targetome analysis during HCMV infection 1.87
Transcriptional landscape changes during human embryonic stem cell derivation 1.87
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 1.87
Transcriptome landscape of HeLa response upon triamcinolone acetonide 1.84
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.82
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.8
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 1.79
An siRNA screen identifies CHD4 as a target for epigenetic therapy 1.78
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.78
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.77
RNA-seq of MDA-MB-231 cells with TET1 knockout 1.75
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.66
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.66
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.66
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.61
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.59
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.59
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.59
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 1.56
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 1.55
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.54
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.53
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 1.52
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.51
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 1.5
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.49
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 1.48
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 1.45
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.45
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 1.43
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.4
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 1.35
The transcriptome and chromatin accessbility landscape of mammalian germline 1.32
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.32
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.32
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.32
HBEC-shp53-PCHD7 1.3
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.29
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 1.2
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 1.18
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 1.18
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.16
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.16
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 1.15
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 1.14
A code of mono-phosphorylation modulates the function of RB. 1.08
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 1.06
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.06
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 1.04
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.01
Copper Regulation of HIF-1 Transcription Activity 1.01
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.01
Effects of transcription on genome - nuclear lamina interactions 1.01
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.98
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 0.94
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.9
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.9
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.88
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.87
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 0.85
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.78
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.77
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.77
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.76
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.74
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.72
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 0.69
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 0.69
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.68
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.68
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.68
Transcriptome-wide modulation of splicing by the exon junction complex 0.62
Aneuploidy triggers an immune response 0.61
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.58
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.56
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.55
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 0.44
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.43
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.43
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.42
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.39
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.36
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.33
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.33
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.32
Identification of a LIF-responsive replication-competent human β cell 0.31
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.31
m6A-dependent regulation of messenger RNA stability 0.31
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.31
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.29
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.26
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.26
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.25
BACH2 in human plasma cell fate decision 0.24
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.2
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.17
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.15
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.14
Zika virus directly infects human peripheral neurons and induces cell death 0.11
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.1
Modulation of nonsense-mediated decay by rapamycin 0.1
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 0.08
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.08
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.06
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.05
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 0.04
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation